COMMUNIQUÉS West-GlobeNewswire

-
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
02/04/2024 -
Spectral Medical Chair to Retire From the Board of Directors
02/04/2024 -
Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
02/04/2024 -
Traws Pharma Announces New Employee Inducement Grants
02/04/2024 -
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
02/04/2024 -
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
02/04/2024 -
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
02/04/2024 -
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
02/04/2024 -
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
02/04/2024 -
Hexiris Welcomes Dr. Paul Harasymowycz to Its Scientific Committee
02/04/2024 -
Bio-Path Holdings Provides 2024 Clinical and Operational Update
02/04/2024 -
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
02/04/2024 -
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
02/04/2024 -
Sweetwater Brewing Unveils New 420 Variety Pack
02/04/2024 -
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
02/04/2024 -
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
02/04/2024 -
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
02/04/2024 -
Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company
02/04/2024 -
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
02/04/2024
Pages